ouabain has been researched along with Gestational Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burke, SD; Cerdeira, AS; Geahchan, C; George, EM; Granger, JP; Karumanchi, SA; Rajakumar, A; Rana, S; Salahuddin, S | 1 |
Su, P; Wu, L; Xiong, C | 1 |
2 other study(ies) available for ouabain and Gestational Hypertension
Article | Year |
---|---|
Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway.
Topics: Animals; Blood Pressure; Cardenolides; Cardiotonic Agents; Cells, Cultured; Digitoxin; Dose-Response Relationship, Drug; Female; HSP27 Heat-Shock Proteins; Humans; Hypertension, Pregnancy-Induced; Hypoxia-Inducible Factor 1, alpha Subunit; Ouabain; Phosphorylation; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Endogenous ouabain in hypertensive disorder complicating pregnancy.
Topics: Adult; Case-Control Studies; Endothelin-1; Female; Humans; Hypertension, Pregnancy-Induced; Nitric Oxide; Ouabain; Placenta; Pregnancy | 2007 |